Vilde Drageset Haakensen

8PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 07, 2026
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.

|May 27, 2026
Prospective evaluation and clinical outcomes of adaptive radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC).

|Mar 19, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

Frigg Å Sommervoll, Henrik Horndalsveen, Dag Einar Sommervoll

|Dec 13, 2022
[Checkpoint inhibitor-induced myocarditis]

Geeta Gulati, Kristin Holm Tjessem, Henrik Horndalsveen

|Nov 04, 2022
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.

Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard

|May 30, 2020
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy.

Vilde D Haakensen, Anand Khadse, Vandana Sandhu

Pageof 2

Frequent Collaborators

3 joint publications

Henrik Horndalsveen

2 joint publications

Jussi Koivunen

2 joint publications

Tarje Onsøien Halvorsen

2 joint publications

Bjørn Henning Grønberg